Listed

Leonardo DRS, Inc.: Form 10-Q for the period ended Mar 31, 2022

Filed with the SEC on May 16, 2022 and accepted by EDGAR at May 16, 2022, 15:49 ET.

Share

Management's discussion and analysis

As filed, 53,276 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

You should read this discussion together with our consolidated financial statements and related notes thereto included elsewhere in this Quarterly Report.

This discussion and other parts of this Quarterly Report include forward-looking statements such as those relating to our plans, objectives, expectations and beliefs, which involve risks, uncertainties and assumptions. These forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to, the risks and uncertainties discussed under “Special Note Regarding Forward-Looking Statements and Information” in this Quarterly Report and under “Risk Factors” in our annual report on Form 10-K, filed with the SEC on March 28, 2022. Actual results may differ materially from those contained in any forward-looking statements.

Business Overview and Considerations

General

DRS is a leading provider of defense products and technologies that provide battlefield superiority today while shaping the battlefield of tomorrow for the U.S. military and our allies abroad. We offer a broad portfolio of products and services in our core technologies including advanced sensing, electronic warfare (“EW”) and cyber, network computing, communications, force protection, and electrical power conversion and propulsion. Our leadership positions in these markets have created a foundational base of programs within the DoD that has yielded five straight years of organic revenue growth. We believe these technologies will not only support our Armed Services in today’s mission but will also underpin the DoD’s strategy to migrate towards more autonomous, dynamic, interconnected, and multi-domain capabilities needed to win in tomorrow’s battlefield. We expect that the DoD’s focus on effectively countering growing peer threats from China and Russia while simultaneously pursuing a counter-terrorism strategy against asymmetrical organizations and actors will increase its reliance on the core technologies that DRS provides, reinforcing our position in our high growth markets.

Our overall strategy includes being a balanced and diversified company, less vulnerable to any one budgetary platform or service decision with a specific focus on establishing strong technical and market positions in areas of priority for the Department of Defense (“DoD”). The DoD is our largest customer and for the three months ended March 31, 2022, accounted for approximately 85% of our business as an end-user, with revenues principally derived directly or indirectly from contracts with the U.S. Army and U.S. Navy, which represented 33% and 36%, respectively, of our total revenues, which is consistent with historic trends.

Our operations and reporting are structured into the following two technology driven segments based on the capabilities and solutions offered to our customers:

Advanced Sensing and Computing (“ASC”): Our Advanced Sensing and Computing segment is organized to provide equipment that enables the capture and communication of value battlefield information necessary to ensure our armed forces are equipped with real-time intelligence required to deliver enhanced decision making and execution in theater. From leading long-range sensing capabilities, expanding our reach, to rugged, trusted, and cyber resilient computing, our ASC products provide our customers with the ability to be successful in their mission.

Our ASC segment provides ground vehicle systems including third generation infrared, long-range threat detection, situational awareness, targeting and vehicle protection. Additionally, we offer a full complement of soldier systems, including next generation sensors, targeting systems and optics to improve infantry combat effectiveness. Our sensing technologies also support aircraft survivability through advanced two-color infrared sensors and our quantum cascade lasers which detect and protect aircraft from missile attacks.

In addition to our optical sensing systems, we utilize state of the art technology in EW and cyber systems to provide our customers integrated capabilities for multi-domain operations to supplement kinetic warfare. Our mounted and dismounted EW systems and intelligence solutions across a broad range of platforms bring world-class capability to our customers.

Our sensing capabilities are complemented by our network computing and communications products. We are the leading global supplier of battle management systems and mounted computing hardware for ground forces worldwide. For the U.S. and allied naval customers, we provide naval computing systems and networks, shipboard communications, radar, surface ship and submarine combat and command and control systems.

Integrated Mission Systems (“IMS”): Our Integrated Mission Systems segment consists of both land and naval system integration capabilities. The IMS segment provides critical force protection, vehicle integration, transportation and logistics and electrical control, distribution and conversion, and ship propulsion systems to the U.S. military and allied forces.

Our force protection systems provide protection for our service members and military assets from evolving threats and include advanced solutions for counter-unmanned aerial systems, short-range air defense systems and active protection systems on ground vehicles. We have military transportation and logistics offerings and ground vehicle integration capabilities to support U.S. forces in a wide range of operational environments.

Additionally, we provide power conversion and propulsion systems for the U.S. Navy’s top priority shipbuilding programs, building on our legacy of providing power components and systems for nearly all naval combat vessels for three decades, positioning us to continue as a leading provider of electrical ship propulsion systems and components for the U.S. Navy.

Focus on Customer and Execution

DRS and its employees focus on our end-customers – the men and women of the armed forces in the U.S. and its allies. We seek to provide high-quality equipment and services to support their mission success. We strive for excellence in everything we do, in every job in our Company, in order to satisfy our customers’ needs embedded in our contractual commitments. We seek to ensure that we learn from every lesson experienced in our Company and insist that these lessons affect all elements of our businesses. This approach permeates through the Company with a focus on continuous improvement at every level.

Part of this learning has resulted in institutionalizing our continuous improvement process through our Operational Excellence initiative called “Always Performing For Excellence,” or “APEX,” program. The APEX program’s goal is to strive for continuous improvement through unification of our business practices, tools and metrics, ongoing employee training and innovation. We believe that excellence is not a destination, but by constantly challenging ourselves to be better, we will improve, and ultimately approach excellence. We challenge ourselves to exceed our customers’ expectations and we partner with them to work to ensure that our execution meets their needs.

Continuous improvement, through the APEX program also allows us to improve our efficiency, which contributes to increased margins, helps us to remain competitive and allows us to make strategic investments, all while maintaining our focus on customer satisfaction. In these elements, our goals are aligned with those of our customers. We are humbled by the dedication and sacrifice that our ultimate customers have made to serve and we work to perform for them with excellence in everything we do.

Impacts of COVID-19 On Our Business

The coronavirus (COVID-19) pandemic has caused significant disruptions to national and global economies and government activities since March 2020. We continue to closely monitor COVID-related impacts on all aspects of our business and geographies, including on our workforce, supply chain and customers.

The United States has taken several steps to respond to the pandemic. On September 9, 2021, President Biden announced a COVID-19 action plan, including an executive order, the Safer Workforce Task Force guidance issued on September 24, 2021 and the DoD’s Force Health Protection guidance. This executive order and guidance (as amended) contained a clause that required covered federal contractors and subcontractors to implement federally required vaccine mandates. This clause was implemented into several of our applicable federal contracts. In light of certain of certain court orders, however, the office of Management and Budget has stated that the U.S Government will not take action to enforce this clause until further notice. If ultimately upheld, this federal contract requirement may impact several of our contracts. We are continuing to evaluate these evolving requirements, especially as our customers determine when and how to implement the potential contractual requirements. We cannot at this stage predict the various impacts they may have on our workforce, our suppliers, or our company. These evolving government requirements, along with broader impacts of the continuing pandemic, could impact our workforce and performance, as well as those of our suppliers

During the quarter we determined that any remaining additional costs to operate our business in response to the COVID-19 environment should be reported as part of our normal business operations and not separately identified as an adjustment to EBITDA.

Business Environment

Revenues derived directly, as a prime contractor, or indirectly, as a subcontractor, from contracts with the U.S. government represented 85% of our consolidated revenue for the three months ended March 31, 2022 and 86% for the three months ended March 31, 2021. Of these sales directly to the U.S. government the Army and Navy are our largest customers. For the three months ended March 31, 2022 and 2021, U.S. government sales with the U.S. Army represented 33% and 44% of our total sales respectively while sales to the U.S. Navy represented 36% and 29% of our total revenues over the same periods.

The first quarter of calendar year 2022 began with the Department of Defense (DoD) operating under another continuing resolution with funding levels set at the prior year 2021 omnibus appropriation level. In early March, Congress passed, and the President signed into law, the full-year Fiscal Year (FY) 22 omnibus appropriations bill.

The $1.5 trillion, FY2022 omnibus appropriations bill allocates $782 billion for overall national security spending ($728 billion to DoD) as well as $14 billion in Ukrainian aid. It exceeded the President’s $715 billion budget request for the Defense Department. The bill provides $1.5 trillion across the 12 regular spending bills, including $730 billion in non-defense discretionary spending, a 6.7% increase from FY2021, and $782 billion in defense spending, a 5.6% increase from FY2021. Federal agencies had been operating under short-term continuing resolutions that extended FY2021 funding for more than five months. The Pentagon received $728.5 billion for FY2022 in the defense portion of the measure, an increase of $32.5 billion from FY2021. The bill provides $144.5 billion in procurement ($12.4 billion more than the President’s FY2022 budget request) and $119.2 billion in research, development, test and evaluation ($7.2 billion more than the President’s FY2022 budget request). Additionally, the bill eliminates Overseas Contingency Operations funding (OCO) in step with the President’s budget request. OCO funding was used to cover combat operations and other activities, and to provide amounts outside of the spending caps that expired after FY2021.

In February 2022, Russian forces invaded Ukraine. In response, the United States and several other countries imposed economic and trade sanctions, export controls and other restrictions (collectively, global sanctions) targeting Russia and Belarus. The conflict and these sanctions have caused disruptions to global economies and some global businesses, including heightened cybersecurity risks, supply chain challenges, increased energy costs, foreign currency exchange rate fluctuations, as well as an exacerbation of existing inflationary pressures.

In addition, the Russia-Ukraine conflict has created some potential supply chain challenges, which we will continue to monitor and manage. The conflict may impact the FY 2023 U.S. government defense budget due to the heightened national security threat. Internationally, many countries in the region have expressed a renewed commitment to defense-related spending. As a result, we may see additional demand for our products and services.

Key Financial and Operating Measures

Overview

We measure our business using both key financial and operating data including key performance indicators (“KPIs”) and non-GAAP financial measures and use the following metrics to manage our business, monitor results of operations and ensure proper allocation of capital: (i) Revenue, (ii) Bookings, (iii) Backlog, (iv) Adjusted EBITDA, (v) Adjusted EBITDA Margin, (vi) Adjusted Earnings Per Share (“EPS”) and (vii) Free Cash Flow. We believe that these financial performance metrics represent the primary drivers of value enhancement, balancing both short and long-term indicators of increased shareholder value. These are the metrics we use to measure our results and evaluate our business and related contract performance. See “—Results from Operations” for further detail.

Financial and Operating Data

(Dollars in millions, except per share amounts)

March 31, 2022 March 31, 2021
Total revenues $612 $681
Bookings $747 $715
Backlog $2,995 $3,326
Adjusted EBITDA(1) $73 $71
Adjusted EBITDA Margin(1) 11.9% 10.4%
Adjusted EPS(1)(2) $0.26 $0.25
Free Cash Flow(1) $(268) $(262)

(1) Note on non-GAAP financial measures: Throughout the discussion of our results of operations we use non-GAAP financial measures including Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted EPS and Free Cash Flow, as measures of our overall performance. Definitions and reconciliations of these measures to the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP are included below.

(2) Gives effect to a 1,450,000-for-1 forward stock split on our common stock effected on February 25, 2021.

Bookings - We define bookings as the total value of contract awards received from the U.S. government for which it has appropriated funds and legally obligated such funds to the Company through a contract or purchase order, plus the value of contract awards and orders received from customers other than the U.S. government.

Backlog - We define Backlog to include the following components:

(1) Funded - Funded backlog represents the revenue value of orders for services under existing contracts for which funding is appropriated or otherwise authorized less revenue previously recognized on these contracts.

(2) Unfunded - Unfunded backlog represents the revenue value of firm orders for products and services under existing contracts for which funding has not yet been appropriated less funding previously recognized on these contracts.

The unfunded and funded backlog combine to equal the total backlog as depicted in the table below at the date presented:

(Dollars in millions)

Backlog: March 31, 2022
Total Backlog 2,995

Non-GAAP Financial Measures

We believe the non-GAAP financial measures presented in this Quarterly Report will help investors understand our financial condition and operating results and assess our future prospects. We believe these non-GAAP financial measures, each of which is discussed in greater detail below, are important supplemental measures because they exclude unusual or non-recurring items as well as non-cash items that are unrelated to or may not be indicative of our ongoing operating results. Further, when read in conjunction with our U.S. GAAP results, these non-GAAP financial measures provide a baseline for analyzing trends in our underlying businesses and can be used by management as a tool to help make financial, operational and planning decisions. Finally, these measures are often used by analysts and other interested parties to evaluate companies in our industry by providing more comparable measures that are less affected by factors such as capital structure.

We recognize that these non-GAAP financial measures have limitations, including that they may be calculated differently by other companies or may be used under different circumstances or for different purposes, thereby affecting their comparability from company to company. In order to compensate for these and the other limitations discussed below, management does not consider these measures in isolation from or as alternatives to the comparable financial measures determined in accordance with U.S. GAAP. Readers should review the reconciliations below and should not rely on any single financial measure to evaluate our business.

We define these non-GAAP financial measures as:

Adjusted EBITDA and Adjusted EBITDA Margin - We define Adjusted EBITDA as our net earnings before income taxes, amortization of acquired intangible assets, depreciation, restructuring costs, interest, deal related transaction cost, acquisition and divestiture related expenses, foreign exchange, COVID-19 response costs, non-service pension expenditures and other one-time non-operational events. Adjusted EBITDA Margin is calculated by dividing Adjusted EBITDA by revenue. Adjusted EBITDA and Adjusted EBITDA Margin are not measures calculated in accordance with U.S. GAAP, and they should not be considered an alternative to any financial measures that were calculated under U.S. GAAP. Adjusted EBITDA and Adjusted EBITDA Margin are used to facilitate a comparison of the ordinary, ongoing and customary course of our operations on a consistent basis from period to period and provide an additional understanding of factors and trends affecting our business. Adjusted EBITDA and Adjusted EBITDA Margin are driven by changes in volume, performance, contract mix and general and administrative expenses and investment levels. Performance, as used in this definition, refers to changes in profitability and is primarily based on adjustments to estimates at completion on individual contracts. These adjustments result from increases or decreases to the estimated value of the contract, the estimated costs to complete the contract, or both. These measures therefore assist management and our board and may be useful to investors in comparing our operating performance consistently over time as they remove the impact of our capital structure, asset base and items outside the control of the management team and expenses that do not relate to our core operations. Adjusted EBITDA and Adjusted EBITDA Margin may not be comparable to similarly titled non-GAAP measures used by other companies as other companies may have calculated the measures differently. The reconciliation of Adjusted EBITDA to net earnings (loss) is provided below:

Consolidated Entity Adjusted EBITDA Reconciliation:

(Dollars in millions)

Three Months Ended March 31, 2022 2021
Net earnings $36 $29
Income tax provision (benefit) 12 $12
Amortization of intangibles 2 $2
Depreciation 13 12
Restructuring costs — —
Interest expense 8 9
Deal related transaction costs 2 4
Foreign exchange — —
COVID-19 response costs — 3
Non-service pension expense — —
Other one-time non-operational events — —
Adjusted EBITDA $73 $71

Adjusted EPS – We calculate Adjusted EPS by excluding deal related transaction costs, acquisition and divestiture related expenses and COVID-19 response costs from our net earnings (loss) to arrive at Adjusted EPS. We believe that Adjusted EPS allows investors to effectively compare our core performance from period to period by excluding items that are not indicative of, or are unrelated to, results from our ongoing business operations such as our capital structure, significant non-cash expenses, the impacts of financing decisions on earnings, and items incurred outside the ordinary, ongoing and customary course of our business. Adjusted EPS has limitations as an analytical tool and does not represent, and should not be considered an alternative to basic or diluted EPS as determined in accordance with U.S. GAAP. The reconciliation of Adjusted EPS to U.S. GAAP EPS is shown below:

Consolidated Entity Reconciliation of Adjusted EPS:

(Dollars in millions, except per share amounts)

Three Months Ended March 31, 2022 2021
Net earnings $36 $29
Deal related transaction costs 2 4
COVID-19 response costs — 3
Adjusted net earnings $38 $36
Adjusted EPS (1) $0.26 $0.25

(1) Gives effect to a 1,450,000-for-1 forward stock split on our common stock effected on February 25, 2021.

Free Cash Flow – We define free cash flow as the sum of the cash flows provided by operating activities and the cash flows provided by (used in) investment activities pertaining to capital expenditures and proceeds generated from the sale of capital assets.

We believe that free cash flow provides management and investors with an important measure of our ability to generate cash on a normalized basis. Free cash flow also provides insight into our flexibility to allocate capital and pursue opportunities that may enhance shareholder value. We believe that while expenditures and dispositions of property plant and equipment will fluctuate period to period, we seek to ensure that we have adequate capital on hand to maintain ongoing operations and enable growth of the business. Additionally, free cash flow is of limited usefulness, in that it does not represent residual cash flows available for discretionary expenditures, due to the fact the measures do not deduct the payments required for debt service and other contractual obligations or payments. The reconciliation between free cash flow and net cash provided by operating activities (the most comparable U.S. GAAP measure) is shown below:

Consolidated Entity Reconciliation of Free Cash Flow:

(Dollars in millions)

Three Months Ended March 31, 2021 2021
Net cash used in operating activities $(255) $(249)
Capital expenditures (13) (13)
Proceeds from sales of assets — —
Free cash flow $(268) $(262)

32

Factors Impacting Our Performance

U.S. Government Spending and Federal Budget Uncertainty

Changes in the volume and relative mix of U.S. government spending as well as areas of spending growth could impact our business and results of operations. In particular, our results can be affected by shifts in strategies and priorities on homeland security, intelligence, defense-related programs, infrastructure and urbanization and continued increased spending on technology and innovation, including cybersecurity, artificial intelligence, connected communities and physical infrastructure. Cost-cutting and efficiency initiatives, current and future budget restrictions, spending cuts and other efforts to reduce government spending and shifts in overall priorities (for example, in response to the COVID-19 pandemic) could cause our government customers to reduce or delay funding or invest appropriated funds on a less consistent basis or not at all, and demand for our solutions or services could diminish. Furthermore, any disruption in the functioning of government agencies, including as a result of government closures and shutdowns, could have a negative impact on our operations and cause us to lose revenue or incur additional costs due to, among other things, our inability to maintain access and schedules for government testing or deploy our staff to customer locations or facilities as a result of such disruptions.

There is also uncertainty around the timing, extent, nature and effect of Congressional and other U.S. government actions to address budgetary constraints, caps on the discretionary budget for defense and non-defense departments and agencies, and the ability of Congress to determine how to allocate the available budget authority and pass appropriations bills to fund both U.S. government departments and agencies that are, and those that are not, subject to the caps. Additionally, budget deficits and the growing U.S. national debt, including as a result of legislative actions in response to the COVID-19 pandemic, may increase pressure on the U.S. government to reduce federal spending across all federal agencies, with uncertainty about the size and timing of those reductions. Furthermore, delays in the completion of future U.S. government budgets could in the future delay procurement of the federal government services we provide. A reduction in the amount of, or reductions, delays, or cancellations of funding for, services that we are contracted to provide to the U.S. government as a result of any of these impacts or related initiatives, legislation or otherwise could have a material adverse effect on our business and results of operations.

Operational Performance on Contracts

Revenue, earnings (margin) and the timing of our cash flows depend on our ability to perform on our contracts. When agreeing to contractual terms, our management team makes assumptions and projections about future conditions and events. The accounting for our contracts and programs requires assumptions and estimates about these conditions and events. These projections and estimates assess:

  • the productivity and availability of labor;
  • the allocation of indirect costs to labor and material costs incurred
  • the complexity of the work to be performed;
  • the cost and availability of materials and components; and
  • schedule requirements.

If there is a significant change in one or more of these circumstances, estimates or assumptions, or if the risks under our contracts are not managed adequately, the profitability of contracts could be adversely affected. This could affect earnings and margin materially.

In particular, profitability can fluctuate predicated on the type of contract awarded. Typically fixed-price development programs on complex systems represent a higher risk profile to complete on-budget. To the extent our fixed-price development efforts create a larger portion of our revenue output, this may result in reduced operating margins given the higher risk profile. The following represents the impact that changing certain of our estimates, particularly those regarding our fixed-price development programs, would have had have on our revenues:

Impact of Change in Estimates on our Revenue Results

(Dollars in millions)

Three Months Ended March 31, 2022 2021
Revenue $(1) $(1)
Total % of Revenue —% —%

Additionally, the timing of our cash flows is impacted by the timing of achievement of billable milestones on contracts. Historically, this has resulted and could continue to result in fluctuations in working capital levels and quarterly free cash flow results. As a result of such quarterly fluctuations in free cash flow results, we believe that quarter-to-quarter comparisons of our results of operations may not necessarily be meaningful and should not be relied upon as indicators of future performance.

Regulations

Increased audit, review, investigation and general scrutiny by U.S. government agencies of performance under government contracts and compliance with the terms of those contracts and applicable laws could affect our operating results. Negative publicity and increased scrutiny of government contractors in general, including us, relating to government expenditures for contractor services and incidents involving the mishandling of sensitive or classified information as well as the increasingly complex requirements of the DoD and the United States intelligence community, including those related to cybersecurity, could impact our ability to perform in the markets we serve.

International & Commercial Sales

International revenue, including foreign military sales, foreign military financing, and direct commercial sales, accounted for approximately 15% of our revenue for the three months ended March 31, 2022 which is consistent with prior year trends. Since our focus is primarily with the DoD and our investments are focused as such, we anticipate that international sales will continue to account for a similar percentage of revenue in the future. We remain subject to the spending levels, pace and priorities of the U.S. government as well as international governments and commercial customers, and to general economic conditions that could adversely affect us, our customers and our suppliers.

Additionally, some international sales may expose us to foreign exchange fluctuations and changing dynamics of foreign competitiveness based on variations in the value of the U.S. dollar relative to other currencies. The impact of those fluctuations is reflected throughout our Consolidated Financial Statements, but in the aggregate, did not have a material impact on our results of operations for three months ended March 31, 2022.

Acquisitions, Divestitures and Held for Sale

We consider the acquisition of businesses and investments that we believe will expand or complement our current portfolio and allow access to new customers or technologies. We also may explore the divestiture of businesses that no longer meet our needs or strategy or that could perform better outside of our organization. On March 21, 2022 we announced the signing of a definitive sale agreement for 100% of the stock of our Global Enterprise Solutions (GES) operating unit.and on April 19, 2022 we signed a definitive sale agreement for our 51% ownership stake in our Advanced Acoustics Concepts Joint Venture with Thales (AAC). The assets and liabilities of GES and our investment in AAC have both been classified as held for sale on the Consolidated Balance Sheet as of March 31, 2022.

Components of Operations

Revenue

Revenue consists primarily of product related revenue, generating 88%, of our total revenues for the period the three months ended March 31, 2022. Our remaining revenue is generated from service related contracts. Additionally, 87% of our revenue is derived from firm-fixed priced contracts for the three months ended March 31, 2022. This is consistent for both contract types when compared to product sales of 84% and firm-fixed sales of 88% for the three months ended March 31, 2021.

Under flexibly priced contracts, we are reimbursed for allowable or otherwise defined total costs (defined as cost of revenues plus allowable general and administrative expenses) incurred, plus a fee. The contracts may also include incentives for various performance criteria, including quality, timeliness, cost-effectiveness or other factors. For the three months ended March 31, 2022 flexible priced contracts represented 13% of our total revenues.

Please refer to Note 1. Summary of Significant Accounting Policies and Note 2. Revenue from Contracts with Customers in the Notes to our Consolidated Financial Statements.

Cost of Revenues

Cost of revenues includes materials, labor and overhead costs incurred in the manufacturing, design, and provision of products and services sold in the period as well as warranty costs. Material costs include raw materials, purchased components and sub-assemblies and outside processing and inbound freight. Labor and overhead costs consist of direct and indirect manufacturing costs, including wages and fringe benefits, operating supplies, depreciation and amortization, occupancy costs, and purchasing, receiving, inspection costs and inbound freight costs.

General and Administrative Expenses

General and administrative expenses include general and administrative expenses not included within cost of revenues such as salaries, wages and fringe benefits, facility costs and other costs related to these indirect functions. Additionally, general and administrative expenses include internal research and development costs as well as expenditures related to bid and proposal efforts. We expect general and administrative expenses will be impacted by the costs associated with being a publicly-traded company.

Results from Operations

The following discussion of operating results is intended to help the reader understand the results of operations and financial condition of the Company, as well as individual segments, for the three months ended March 31, 2022, as compared to three months ended March 31, 2021. Given the nature of our business, we believe revenue and earnings from operations are most relevant to an understanding of our performance at a business and segment level. Our operating cycle is lengthy and involves various types of production contracts and varying delivery schedules. Accordingly, operating results in a particular year may not be indicative of future operating results.

(Dollars in millions, except per share amounts)

Three Months Ended March 31, 2022 March 31, 2021 March 31, 2022 vs. March 31,2021 $%
Total revenues $612 $681 $(69) (10.1)%
Total cost of revenues (478) (545) 67 (12.3)%
Gross profit $134 $136 (2) (1.5)%
Gross margin 21.9% 20.0% 1.9% 9.6%
General and administrative expenses (76) (79) 3 (3.8)%
Amortization of intangibles (2) (2) — —%
Other operating expenses, net — (4) 4 (100.0)%
Operating earnings $56 $51 5 9.8%
Interest expense (8) (9) 1 (11.1)%
Other, net — (1) 1 (100.0)%
Earnings before taxes $48 $41 7 17.1%
Income tax provision 12 12 — —%
Net earnings $36 $29 7 24.1%
Shares outstanding(1) 145 145 $— —%
Basic EPS(1) $0.25 $0.20 $0.05 24.1%
Diluted EPS(1) $0.25 $0.20 $0.05 24.1%
Adjusted EPS(1,2) $0.26 $0.25 $0.01 5.6%
Adjusted EBITDA(2) $73 71 2 2.8%
Adjusted EBITDA Margin(2) 11.9% 10.4% 1.5% 14.4%
Backlog(2) $2,995 2,945 50 1.7%
Bookings(2) 747 715 32 4.5%
Free cash flow(2) $(268) $(262) $(6) 2.3%

NM- percentage change not meaningful

(1) Gives effect to a 1,450,000-for-1 forward stock split on our common stock effected on February 25, 2021.

(2) See “—Non-GAAP Financial Measures” above for definitions of these measures. Adjusted EPS, Adjusted EBITDA, Adjusted EBITDA Margin and free cash flow are non-GAAP measures. See “—Key Financial and Operating Measures—Non-GAAP Financial Measures” above for reconciliations of these measures to the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP.

Our operating results for the three months ended March 31, 2022 realized a reduction in revenue as compared to the prior year three month period ended March 31, 2021. This was largely attributed to supply chain delays impacting material receipts and the continued impact of the COVID-19 on short-term demand levels throughout the various services, reducing the quantity or delays of certain awards during the period. Despite the revenue trend, we improved profitability for the three months ended March 31, 2022 when compared to the three months ended March 31, 2021 predicated on improved contractual performance on our Next Generation Ballistic Submarine program within our IMS segment, resulting in an increase in Adjusted EBITDA of 2.8% and a 150bps increase in our Adjusted EBITDA margin. Additionally, bookings for the three months ended March 31, 2022 increased 4.5% from the three months ended March 31, 2021 due to follow on awards on key programs in our IMS segment including our efforts on the Columbia Class Program.

Revenue of $612 million represented a decrease of $(69) million or (10%) while operating earnings and net earnings grew $5 million (10%) and $7 million (24%) for the three months ending March 31, 2022 when compared to the three months ending March 31, 2021. Adjusted EBITDA increased by $2 million (3%) while adjusted

EBITDA margins also increased by 14% to 11.9% for the three months ended March 31, 2022 when compared to the three months ended March 31, 2021. See below for a detailed explanation of results from operations.

Revenue

Our revenue generation of $612 million represents a decrease of $(69) million or (10)% as compared to the three months ended March 31, 2021. The revenue decrease was largely anticipated and is attributed primarily to award timing, supply chain delays impacting the receipt of electronic components, COVID-19 and the related hindrance to service employment levels impacting delivery and installation of some of our key programs and a prior year ramp up of revenue realized on certain Counter Unmanned Aircraft Systems programs that transitioned into full rate production. The year-over-year revenue decline is attributed to our ASC segment which realized a decrease in revenues of $(87) million or (18%) during the period. The revenue decline was driven by a decrease in sales of our ruggedized computing hardware programs which were impacted by award timing, supply chain delays, as well as the COVID-19 impacts on installation readiness, impacting short-term demand. Partially offsetting this year-over-year decline was a revenue increase of $17 million or 9% as compared to the prior year period at our IMS segment. The increase is primarily attributed to increased progress and funding levels on our submarine programs, offset in part by decreases in our Counter UAS production program revenue as noted above.

Cost of Revenues

Cost of revenue decreased by $67 million or (12)% from $545 million to $478 million primarily due to decreased revenue as described above. Additionally, improved contract performance decreased the cost of revenues as a percentage of revenue highlighted by improved program performance within our IMS segment driving increased margin contribution.

Gross Profit

Gross profit decreased by $2 million, or (1)% to $134 million for the three months ended March 31, 2022 as compared to $136 million for the three months ended March 31, 2021. This was primarily due to the decreased revenue output offset by improved program performance as noted above.

General and Administrative Expenses

General and administrative expenses decreased by $3 million or (4)% for the three months ending March 31, 2022 as compared to the three months ended March 31, 2021. As a percentage of revenue however, general and administrative expenses increased to 12.4% for the three months ended March 31, 2022 from 11.6% for the three months ended March 31, 2021. The primary driver for the decrease in general and administrative expenses is attributed to a reduction in non-recurring deal related expenditures that were incurred in the three months ended March 31, 2021. .

Other Operating Expenses, Net

Other operating expenses decreased by $4 million from $4 million for three months ended March 31, 2021 to $0 million for three months ended March 31, 2022. The expense reduction is primarily attributed to reduction of required employee safety protocols related to COVID-19 recorded in the three months ended March 31, 2021 of $3 million. For the three months ended March 31, 2022, our COVID prevention protocols, including our policy of unlimited paid sick leave for quarantine periods for potentially exposed employees to ensure a safe working environment, were no longer required. We continue to offer bonuses for employees that vaccinate, however, given the high vaccination rates and other safety precautions implemented across our facilities, we have returned to our normal sick leave policies.

Amortization of Intangibles

Amortization of intangibles of $2 million for three months ending March 31, 2022 were consistent with three months ending March 31, 2021 of $2 million.

Operating Earnings

Operating earnings increased by $5 million to $56 million or 10% for three months ended March 31, 2022 from $51 million for three months ended March 31, 2021. The increase was driven by a combination of improved program performance, reduced deal related costs and reduced COVID related expenses as noted above.

Interest Expense

Interest expense remained relatively consistent with an overall decrease of $1 million or 11% to $8 million for ending three months March 31, 2022 from $9 million for ending three months March 31, 2021.

Other, Net

Other, net decreased by $1 million for the three month ended March 31, 2022 to $0 million from $1 million for the three months ended March 31, 2021.

Earnings Before Taxes

Earnings before taxes increased by $7 million to $48 million for three months ended March 31, 2022 from $41 million for three months ended March 31, 2021. This was primarily due to an increase in operating earnings of $5 million, a reduction in interest expense of $1 million and reduction of other costs of $1 million.

Income Tax Provision

Income tax provision remained consistent at $12 million for three months ended March 31, 2022 compared to the three months ended March 31, 2021. This was primarily attributable to increased Earnings Before Taxes in the three months ended March 31, 2022, being offset by unfavorable discrete tax expense recorded during the three months ended March 31, 2021. The discrete items were due to certain state law tax changes and an increase in estimated nondeductible expenses.

Net Earnings

Net earnings increased by $7 million to $36 million for the three months ended March 31, 2022 when compared to the three months ended March 31, 2021. This was driven by increased earnings before taxes of $7 million and Income Tax provision staying constant at $12 million as noted above.

Adjusted EBITDA

Adjusted EBITDA increased by $2 million or 3% to $73 million from $71 million for the three months ended March 31, 2022 as compared to three months March 31, 2021. This was primarily due to improvement in program performance driving increased profitability. This was offset in part by a reduction in revenue as noted above.

Adjusted EBITDA Margin

Adjusted EBITDA Margin increased from 10.4% for the three months ended March 31, 2021 to 11.9% for the three months ended March 31, 2022. This was primarily due to improved program performance and the transition of certain development programs into production driving margin expansion.

Adjusted EPS

For the three months ended March 31, 2022 there were no changes in the number of basic and diluted shares. No equity awards were issued during the period. As of March 31, 2022, there were 145,000,000 shares of common stock outstanding resulting in EPS of $0.26. This increase of $0.01 from $0.25 for the three months ended March 31, 2021 is attributed to the net earnings growth described above.

Backlog

Backlog increased by $50 million to $2,995 million from $2,945 million for three months ended March 31, 2022, from three months ended March 31, 2021. The increase is primarily attributed to bookings growth in our IMS segment driven by the definitization of the certain Counter UAS and Short Range Air Defense programs with the US Army and additional funding on the next generation ballistic submarine program.

Bookings

Bookings results for three months ended March 31, 2022 increased 4% or $32 million to $747 million as compared to $715 million for the three month ended March 31, 2021. The increase is primarily attributed to performance within our IMS segment driven by the definitization of certain Counter UAS and Short Range Air Defense programs with the U.S. Army and additional funding received on our next generation ballistic submarine program with the U.S. Navy. This was partially offset at our ASC segment driven by a reduction of ground vehicle awards received on our ruggedized computing programs with the U.S. Army.

Free cash flow

Free cash flow usage increased by $6 million to $(268) million for three months ended March 31, 2022 from $(262) million for the three months ended March 31, 2021. This was primarily due to cash used to fund working capital for the three months ended March 31, 2022 when compared to three months ended March 31, 2021 driven by a reduction in accounts payable during the period, offset in part by customer advances received.

Review of Operating Segments

The following is a discussion of operating results for each of our operating segments. We have elected to use Revenue, Adjusted EBITDA, Adjusted EBITDA Margin, and Bookings to provide detailed information on our segment performance. Additional information regarding our segments can be found in Note 15: Segment information within the unaudited Consolidated Financial Statements.

(Dollars in millions)

Revenue: Three Months Ended March 31, 2022 2021 March 31, 2022 vs. March 31, 2021 Variance
ASC $396 $483 $(87) (17.9)%
IMS 218 201 17 8.5%
Corporate & Eliminations (2) (3) 1 (28.6)%
Total revenue $612 $681 $(69) (10.1)%
Adjusted EBITDA:
ASC $32 $54 $(22) (40.7)%
IMS 41 18 23 127.8%
Corporate & Eliminations — (1) 1 (100.0)%
Total Adjusted EBITDA $73 $71 $2 2.8%
Adjusted EBITDA Margin:
ASC 8.1% 11.2% (3.1)% (27.8)%
IMS 18.8% 9.0% 9.8% 109.9%
Bookings:
ASC $388 $493 $(105) (21.3)%
IMS 359 222 137 61.9%
Total bookings $747 $715 $32 4.5%

39

ASC

Revenue:

The ASC segment reported revenue of $396 million three months ended March 31, 2022, decreasing by (18%) or $(87) million from the three months ended March 31, 2021. This decrease is primarily attributed to award timing, supply chain delays impacting revenue generation on our ruggedized computing, and various sensing programs with the U.S. Army. Additionally, the ASC segment realized delays in the receipt of awards on certain components to support computing hardware for naval systems.

Adjusted EBITDA and Adjusted EBITDA Margin:

ASC’s Adjusted EBITDA decreased by $(22) million or (41%), from $54 million for three months ended March 31, 2021 to $32 million for three months ended March 31, 2022. The decrease in Adjusted EBITDA drove a reduction in Adjusted EBITDA Margin from 11% for the three months ended March 31, 2021 to 8% for three months ended March 31, 2022. The decrease in Adjusted EBITDA and Adjusted EBITDA Margin is primarily due to decreased revenue volume reducing absorption of general and administrative expenditures. Additionally we experienced certain inflationary impacts on certain Naval radar programs negatively impacting margins for the period.

Bookings:

The ASC segment contributed $164 million in new bookings for three months ended March 31, 2022. Bookings were down 21% or $105 million as compared to the three months ended March 31, 2021. The reduction is primarily due to reduced order quantities on our ruggedized computing programs due to a delay in installation capabilities attributed to COVID employment disruption within the U.S. Army as well as significant ‘lump’ awards received during the three months ended March 31, 2021, including pilot training systems awarded for the JSF lot 15, and multi-year funding received to upgrade legacy ground vehicles with the U.S. Army.

IMS

Revenue:

IMS segment revenue increased by $17 million or 9% to $218 million for the three months ended March 31, 2022 from $201 million for the three months ended March 31, 2021. This increase was primarily attributed to improved progress on our submarine programs as well as sustaining full rate production on our surface ship power system production programs. Our naval increases were offset in part by the production ramp up realized on our Counter UAS and Short Range Air Defense programs in the prior three month period ended March 31, 2021.

Adjusted EBITDA and Adjusted EBITDA Margin:

IMS’s Adjusted EBITDA increased by $23 million or 128% to $41 million for three months ended March 31, 2022 from $18 million for the three months ended March 31, 2021. This was primarily due to improved performance on our Next Generation Ballistic Submarine program and increased revenue contribution and related operational leverage generated as noted above.

Bookings:

Bookings increased by $137 million or 62% for the three months ended March 31, 2022 to $359 million from $222 million for the three months ended March 31, 2021. This was primarily due to increased bookings for our force protection products including the definitization of 124 mission equipment package (MEP) contract to provide short range air defense for the U.S. Army. Additionally, IMS continues to realize increased funding on the Next Generation Ballistic Submarine program as we transition from development into production.

Liquidity and Capital Resources

We endeavor to ensure the most efficient conversion of operating income into cash for deployment in our business and to maximize shareholder value through cash deployment activities. In addition to our cash position, we use various financial measures to assist in capital deployment decision-making, including cash provided by operating activities and free cash flow, a non-GAAP measure described in more detail below. We believe that the combination of our existing cash, access to credit facilities as described in Note 10: Debt and future cash that we expect to generate from our operations will be sufficient to meet our short and long-term liquidity needs. There can be no assurance, however, that our business will continue to generate cash flow at current levels or that anticipated operational improvements will be achieved. We may also pursue acquisitions or other strategic priorities that will require additional liquidity beyond the liquidity we generate through our operations. Our cash balance as of March 31, 2022, was $113 million compared to $240 million as of December 31, 2021.

The following table summarizes our cash flows for the periods presented:

(Dollars in millions)

Three Months Ended March 31, 2022 2021
Net cash used in operating activities $(255) $(249)
Net cash provided by investing activities (13) 102
Net cash provided by financing activities 141 116
Effect of exchange rate changes on cash and cash equivalents — —
Net increase (decrease) in cash and cash equivalents $(127) $(31)
Free cash flow(1) $(268) $(262)

(1) Free cash flow is a Non-GAAP measure. The reasons we use this Non-GAAP financial measure and its reconciliation to the most directly comparable U.S. GAAP financial measure is provided above under “—Key Financial and Operating Measures—Non-GAAP Financial Measures.”

Operating Activities

Cash usage related to the operating activities increased by $(6) million from $(249) million for the three months ended March 31, 2021 to $(255) million for the three months ended March 31, 2022. This was primarily due to cash used to fund working capital for the three months ended March 31, 2022 when compared to three months ended March 31, 2021 driven by a reduction in accounts payable during the period, offset in part by increased net earnings generated and the receipt of certain customer advances.

Investing Activities

Net cash provided by investing activities decreased by $115 million for the three months ended March 31, 2022 the three months ended March 31, 2021. The reduced cash generation was attributed the pay-back of the Surplus Treasury Agreement with US Holding. For the year ended December 31, 2020 we advanced Leonardo U.S. Holdings $115 million which was subsequently repaid in the three months ended March 31, 2021 driving the decrease in investing cash generation as compared to the three months ended March 31, 2022.

Financing Activities

Net cash provided by financing activities increased by $25 million for the three months ended March 31, 2022 versus March 31, 2021. The increase was primarily related to an increase in cash retained on the Balance Sheet as of March 31, 2022 resulting in a reduction in pay-down of debt facilities.

Free Cash Flow

Free cash flow usage increased by $6 million to $(268) million for three months ended March 31, 2022 from $(262) million for the three months ended March 31, 2021. This was primarily due to cash used to fund working capital for the three months ended March 31, 2022 when compared to three months ended March 31, 2021 driven by a reduction in accounts payable during the period, offset in part by customer advances received.

Market risk

As filed, 1,894 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Equity Risk

We currently have limited risk related to fluctuations in marketable securities. Outside of pension assets which are disclosed in Note 11: Pension and Other Postretirement Benefits to the Consolidated Financial Statements, the only investments the Company holds are overnight money market accounts. Fluctuations are unlikely and would have limited impact on the financial statements of the Company.

Interest Rate Risk

We are exposed to interest rate risk on variable-rate borrowings under our revolving credit facilities, which had an outstanding balance of $150 million as of March 31, 2022. Our remaining debt facilities are fixed rate obligations and not subject to fluctuations in interest rates. For additional information please refer to Note 10. Debt .

Foreign Currency Risk

In certain circumstances, we may be exposed to foreign currency risk. However, as the overwhelming majority of our revenue is derived from U.S. sources directly as a prime contractor or indirectly as a subcontractor for the U.S. government as end-customer, we have limited foreign currency exposure. Currently, our exposure is primarily with the Canadian dollar and limited to receivables owed of $55 million as of March 31, 2022. A 10% fluctuation in exchange rates would not have a material impact on our financial statements. We do not enter into or issue derivative instruments for trading purposes.

Inflation Risk

We have generally been able to anticipate increases in costs when pricing our contracts. Bids for longer-term firm fixed-price contracts typically include assumptions for labor and other cost escalations in amounts that historically have been sufficient to cover cost increases over the period of performance. We have seen impacts due to inflation on isolated programs. These have largely been offset with our internal continuous improvement savings initiatives.

Controls and procedures

As filed, 1,488 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the quarterly period ended March 31, 2022, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer has concluded that during the period covered by this report, our disclosure controls and procedures were effective.

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the quarterly period ended March 31, 2022 covered by this Quarterly Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 254 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of the date of this Quarterly Report, there have been no material changes to the risk factors discussed under “Risk Factors” in Part 1, Item 1A of our Annual Report on Form 10-K for the year end December 31, 2021, filed with the SEC on March 28, 2022.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-01-01 to 2022-03-31$612.0mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-01-01 to 2022-03-31$478.0mus-gaap:CostOfRevenue
Gross profit3 months2022-01-01 to 2022-03-31$134.0mus-gaap:GrossProfit
Operating income3 months2022-01-01 to 2022-03-31$56.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-01-01 to 2022-03-31$8.0mus-gaap:InterestExpense
Income tax3 months2022-01-01 to 2022-03-31$12.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-01-01 to 2022-03-31$36.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-01-01 to 2022-03-31$0.25us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-01-01 to 2022-03-31$0.25us-gaap:EarningsPerShareBasic
Operating cash flow3 months2022-01-01 to 2022-03-31−$255.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2022-01-01 to 2022-03-31$13.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2022-03-31$113.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-03-31$1.52bnus-gaap:AssetsCurrent
Total assetsAt period end2022-03-31$3.03bnus-gaap:Assets
Current liabilitiesAt period end2022-03-31$923.0mus-gaap:LiabilitiesCurrent
Current portion of debtAt period end2022-03-31$186.0mus-gaap:DebtCurrent
Short-term borrowingsAt period end2022-03-31$9.0mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2022-03-31$1.64bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-22-014481. Last ingested by Listed: Nov 14, 2026, 21:34 ET. Listed shows no prices and gives no investment advice.